ArticleiGIE : innovation, investigation and insights2026
Submucosal tunneling endoscopic resection in challenging esophageal subepithelial lesions: a minimally invasive approach.
Article in iGIE : innovation, investigation and insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Submucosal tunneling endoscopic resection (STER) is a minimally invasive procedure for resecting esophageal subepithelial lesions (SELs), particularly those arising from the muscularis propria layer. This article presents 2 challenging cases of esophageal SELs successfully managed with STER. Methods: Two esophageal SELs were managed with STER, which involved creating a submucosal tunnel for en bloc resection, followed by closure with hemostatic clips. Challenges related to lesion location, size, and patient comorbidities were addressed during the procedures. Results: Both patients underwent successful en bloc resection of the SELs without adverse events. One presented with progressive dysphagia for 2 years, and the other with dysphagia and intermittent chest pain. Both experienced significant clinical improvement postoperatively. Conclusions: STER offers an effective, minimally invasive alternative to surgery in challenging cases of esophageal SELs, demonstrating excellent results with reduced morbidity when performed with careful planning and multidisciplinary collaboration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.